Literature DB >> 26506222

ADSSL1 mutation relevant to autosomal recessive adolescent onset distal myopathy.

Hyung Jun Park1,2, Young Bin Hong3, Young-Chul Choi2, Jinho Lee3, Eun Ja Kim3, Ji-Su Lee4, Won Min Mo3, Soo Mi Ki4, Hyo In Kim4, Hye Jin Kim5, Young Se Hyun5, Hyun Dae Hong5, Kisoo Nam6, Sung Chul Jung7, Sang-Beom Kim8, Se Hoon Kim9, Deok-Ho Kim10, Ki-Wook Oh11, Seung Hyun Kim11, Jeong Hyun Yoo12, Ji Eun Lee4,13, Ki Wha Chung5, Byung-Ok Choi3,4,14.   

Abstract

OBJECTIVE: Distal myopathy is a heterogeneous group of muscle diseases characterized by predominant distal muscle weakness. A study was done to identify the underlying cause of autosomal recessive adolescent onset distal myopathy.
METHODS: Four patients from 2 unrelated Korean families were evaluated. To isolate the genetic cause, exome sequencing was performed. In vitro and in vivo assays using myoblast cells and zebrafish models were performed to examine the ADSSL1 mutation causing myopathy pathogenesis.
RESULTS: Patients had an adolescent onset distal myopathy phenotype that included distal dominant weakness, facial muscle weakness, rimmed vacuoles, and mild elevation of serum creatine kinase. Exome sequencing identified completely cosegregating compound heterozygous mutations (p.D304N and p.I350fs) in ADSSL1, which encodes a muscle-specific adenylosuccinate synthase in both families. None of the controls had both mutations, and the mutation sites were located in well-conserved regions. Both the D304N and I350fs mutations in ADSSL1 led to decreased enzymatic activity. The knockdown of the Adssl1 gene significantly inhibited the proliferation of mouse myoblast cells, and the addition of human wild-type ADSSL1 reversed the reduced viability. In an adssl1 knockdown zebrafish model, muscle fibers were severely disrupted, which was evaluated by myosin expression and birefringence. In these conditions, supplementing wild-type ADSSL1 protein reversed the muscle defect.
INTERPRETATION: We suggest that mutations in ADSSL1 are the novel genetic cause of the autosomal recessive adolescent onset distal myopathy. This study broadens the genetic and clinical spectrum of distal myopathy and will be useful for exact molecular diagnostics.
© 2015 American Neurological Association.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26506222     DOI: 10.1002/ana.24550

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  5 in total

1.  Anti-apoptotic Effects of Human Wharton's Jelly-derived Mesenchymal Stem Cells on Skeletal Muscle Cells Mediated via Secretion of XCL1.

Authors:  SooJin Kwon; Soo Mi Ki; Sang Eon Park; Min-Jeong Kim; Brian Hyung; Na Kyung Lee; Sangmi Shim; Byung-Ok Choi; Duk L Na; Ji Eun Lee; Jong Wook Chang
Journal:  Mol Ther       Date:  2016-06-23       Impact factor: 11.454

2.  Electron Microscopy Pathology of ADSSL1 Myopathy.

Authors:  Hyung Jun Park; Jee Eun Lee; Gyeong Seon Choi; Heasoo Koo; Soo Jeong Han; Jeong Hyun Yoo; Young Chul Choi; Kee Duk Park
Journal:  J Clin Neurol       Date:  2016-11-17       Impact factor: 3.077

3.  Whole-body muscle MRI of patients with MATR3-associated distal myopathy reveals a distinct pattern of muscular involvement and highlights the value of whole-body examination.

Authors:  Alexander Mensch; Torsten Kraya; Felicitas Koester; Tobias Müller; Dietrich Stoevesandt; Stephan Zierz
Journal:  J Neurol       Date:  2020-05-02       Impact factor: 4.849

4.  Panorama of the distal myopathies.

Authors:  Marco Savarese; Jaakko Sarparanta; Anna Vihola; Per Harald Jonson; Mridul Johari; Salla Rusanen; Peter Hackman; Bjarne Udd
Journal:  Acta Myol       Date:  2020-12-01

5.  Improving the efficacy of exome sequencing at a quaternary care referral centre: novel mutations, clinical presentations and diagnostic challenges in rare neurogenetic diseases.

Authors:  Christopher Grunseich; Nathan Sarkar; Joyce Lu; Mallory Owen; Alice Schindler; Peter A Calabresi; Charlotte J Sumner; Ricardo H Roda; Vinay Chaudhry; Thomas E Lloyd; Thomas O Crawford; S H Subramony; Shin J Oh; Perry Richardson; Kurenai Tanji; Justin Y Kwan; Kenneth H Fischbeck; Ami Mankodi
Journal:  J Neurol Neurosurg Psychiatry       Date:  2021-06-08       Impact factor: 10.154

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.